Belinostat (PXD 101) for the Treatment of Peripheral T-Cell Lymphoma (PTCL)

Belinostat (PXD 101) is a histone deacetylase (HDAC) inhibitor that is being investigated for the treatment of relapsed or refractory (R/R) peripheral T-cell lymphoma (PTCL).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news